Aim: To study the dynamics and contribution of mortality from Diseases of the respiratory system (DRS) in 2019 and 2020 to mortality from all causes with and without deaths from COVID-19 in 82 regions of the Russian Federation.
Materials And Methods: The data provided by Rosstat for 2019 and 2020 on the average annual population and the number of deaths due to causes of DRS (class J00J99) were used the standardised death rate (SDR) were calculated, the regional average value, standard deviation and coefficient of variation.
Results: The average increase in the SDR from DRS in 2020 was 22.1913.22 per 100 thousand population (66.4489.6% higher than in 2019). The average regional SDR from DRS + COVID-19 in 2020 was higher than the SDR from DRS in 2019 by 87.6530.1 per 100 thousand population. The average regional share of SDR in the structure of mortality excluding COVID-19 increased from 3.661.44 to 5.062.49%; taking into account COVID-19, it increased to 10.963.13%. In 16 regions, the SDR from DRS + COVID-19 exceeded the increase in mortality from all causes. No correlation was found between SDR (2020) from all causes and SDR from COVID-19 (r=0.09; p=0.39); an inverse correlation was found between SDR from DRS and SDR from COVID-19 in 2020 (r=-0.42; p0.0001).
Conclusion: Against the background of high interregional variability of SDR from DRS in most regions, an increase in the mortality rate from DRS and the contribution of DRS to total mortality in 2020 was registered.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.26442/00403660.2022.03.201403 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Patient Preferences for Features Associated With Leadless Versus Conventional Transvenous Cardiac Pacemakers.
Circ Cardiovasc Qual Outcomes
December 2024
Duke Clinical Research Institute (S.D.R., J.-C.Y., M.J.W., J.S., F.R.J., S.O., S.M.A.-K.), Duke University School of Medicine, Durham, NC.
Article Synopsis
- A study examined patient preferences for different types of pacemakers, including new dual-chamber leadless options and traditional transvenous ones, to identify which features are most important to them.
- Surveying 117 patients, researchers found that half preferred leadless pacemakers while the other half favored conventional ones, highlighting a significant division in choices.
- Key factors influencing patient decisions included preferred pacemaker type, acceptance of complication and infection risks, and the time since regulatory approval, with many willing to accept higher risks for their preferred options.
Initiation of Statins for Primary Prevention in Heart Failure With Preserved Ejection Fraction.
JACC Adv
April 2024
Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.
Article Synopsis
- Statins are effective in preventing cardiovascular disease and reducing mortality, but their benefits in adults with heart failure and preserved ejection fraction (HFpEF) without prior cardiovascular issues are not well-documented.
- This study analyzed data from nearly 8,000 veterans to assess the impact of starting statins on mortality and major adverse cardiovascular events (MACE) in patients newly diagnosed with HFpEF and without a history of atherosclerotic cardiovascular disease.
- Results indicated that veterans who initiated statins had a 22% lower risk of all-cause mortality and a reduced risk of MACE and hospitalizations compared to non-users, suggesting statins may offer significant benefits for this patient group.
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice.
Hamostaseologie
March 2024
Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland.
We describe the case of a 38-year-old man with a history of chronic portal vein thrombosis who presented with abdominal pain after a transjugular intrahepatic portosystemic shunt procedure. Under anticoagulation therapy with rivaroxaban, he experienced active splenic bleeding, leading to hemodynamic instability. Emergency interventions, including andexanet alfa and nanoparticle administration, successfully stopped the bleeding.
View Article and Find Full Text PDFPredicting Survival for Veno-Arterial ECMO Using Conditional Inference Trees-A Multicenter Study.
J Clin Med
September 2023
Institute of Anesthesiology, University and University Hospital Zurich, 8091 Zurich, Switzerland.
Article Synopsis
- - The study focuses on creating a predictive model using machine learning to assess in-hospital mortality risk for patients undergoing veno-arterial extracorporeal membrane oxygenation (VA-ECMO), aiming to improve clinical decision-making prior to ECMO initiation.
- - Researchers analyzed data from 837 patients to develop and validate a model using two variable sets (small and comprehensive), finding similar error rates (~35%) and a moderate area under the curve (AUC) between 0.70 and 0.71, indicating decent predictive ability.
- - External validation showed varied performance, with higher error rates and lower AUCs (0.60 to 0.63), suggesting that while the model provides useful insights, there may
Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC).
Curr Oncol
March 2023
CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA 98195, USA.
To compare efficacy outcomes for all approved and investigational first-line (1L) treatment regimens for locally advanced or metastatic urothelial carcinoma (la/mUC) with standard of care (SOC), a network meta-analysis (NMA) was conducted. A systematic literature review (SLR) identified phase 2 and 3 randomized trials investigating 1L treatment regimens in la/mUC published January 2001-September 2021. Three networks were formed based on cisplatin (cis) eligibility: cis-eligible/mixed (cis-eligible patients and mixed populations of cis-eligible/ineligible patients), cis-ineligible (strict; exclusively cis-ineligible patients), and cis-ineligible (wide; including studies with investigator's choice of carbo).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!